Procter AW - Search Results

1

Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.

Palmer AM, Stratmann GC, Procter AW, Bowen DM. Palmer AM, et al. Among authors: procter aw. Ann Neurol. 1988 Jun;23(6):616-20. doi: 10.1002/ana.410230616. Ann Neurol. 1988. PMID: 2457353

2

Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms.

Procter AW, Francis PT, Stratmann GC, Bowen DM. Procter AW, et al. Neurochem Res. 1992 Sep;17(9):917-22. doi: 10.1007/BF00993268. Neurochem Res. 1992. PMID: 1357564

3

A glycine site as therapeutic target.

Francis PT, Procter AW, Bowen DM. Francis PT, et al. Among authors: procter aw. Ann N Y Acad Sci. 1991;640:184-8. doi: 10.1111/j.1749-6632.1991.tb00214.x. Ann N Y Acad Sci. 1991. PMID: 1663714 Review. No abstract available.

4

Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.

Procter AW, Wong EH, Stratmann GC, Lowe SL, Bowen DM. Procter AW, et al. J Neurochem. 1989 Sep;53(3):698-704. doi: 10.1111/j.1471-4159.1989.tb11760.x. J Neurochem. 1989. PMID: 2569500

5

Loss of glycine-dependent radioligand binding to the N-methyl-D-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease.

Procter AW, Stirling JM, Stratmann GC, Cross AJ, Bowen DM. Procter AW, et al. Neurosci Lett. 1989 Jun 5;101(1):62-6. doi: 10.1016/0304-3940(89)90441-2. Neurosci Lett. 1989. PMID: 2570384

6

Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.

Bowen DM, Najlerahim A, Procter AW, Francis PT, Murphy E. Bowen DM, et al. Among authors: procter aw. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9504-8. doi: 10.1073/pnas.86.23.9504. Proc Natl Acad Sci U S A. 1989. PMID: 2574463 Free PMC article.

7

Topographical distribution of neurochemical changes in Alzheimer's disease.

Procter AW, Lowe SL, Palmer AM, Francis PT, Esiri MM, Stratmann GC, Najlerahim A, Patel AJ, Hunt A, Bowen DM. Procter AW, et al. J Neurol Sci. 1988 Apr;84(2-3):125-40. doi: 10.1016/0022-510x(88)90118-9. J Neurol Sci. 1988. PMID: 2898011

8

Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease.

Procter AW, Palmer AM, Francis PT, Lowe SL, Neary D, Murphy E, Doshi R, Bowen DM. Procter AW, et al. J Neurochem. 1988 Mar;50(3):790-802. doi: 10.1111/j.1471-4159.1988.tb02983.x. J Neurochem. 1988. PMID: 3339353

9

Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.

Lowe SL, Francis PT, Procter AW, Palmer AM, Davison AN, Bowen DM. Lowe SL, et al. Among authors: procter aw. Brain. 1988 Aug;111 ( Pt 4):785-99. doi: 10.1093/brain/111.4.785. Brain. 1988. PMID: 3401683

10

Antemortem measurements of neurotransmission: possible implications for pharmacotherapy of Alzheimer's disease and depression.

Francis PT, Pangalos MN, Stephens PH, Bartlett JR, Bridges PK, Malizia AL, Neary D, Procter AW, Thomas DJ, Bowen DM. Francis PT, et al. Among authors: procter aw. J Neurol Neurosurg Psychiatry. 1993 Jan;56(1):80-4. doi: 10.1136/jnnp.56.1.80. J Neurol Neurosurg Psychiatry. 1993. PMID: 7679142 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters